|
| Own Slots | ||
|---|---|---|
| Slot Name | Value | |
 |
Alternatives | |
|
CanImprove | |
|
CautionWithMedicationsUsed | |
|
Comment | |
|
Contraindication | |
|
CouldBeRelatedTo | Cerebral_infarction, Atrial_fibrillation |
|
Cui | C0043031 |
|
Definition | An anticoagulant that acts by inhibiting the synthesis of vitamin K-dependent coagulation factors. Warfarin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, pulmonary embolism, and atrial fibrillation with embolization. It is also used as an adjunct in the prophylaxis of systemic embolism after myocardial infarction. Warfarin is also used as a rodenticide. |
|
DespiteReceivingTreatment | |
|
DoNotUseWithMedicationGroup | |
|
EspeciallyEffectiveAgainst | |
|
Improves | Atrial_fibrillation |
|
Incrementsmgday | |
|
InitiatingDose | |
|
MaintenanceDose | |
|
MaximumRecommendedDailyDose | |
|
MeanDailyDose | |
|
RelevantSignOrSymptom | |
|
SideEffect | |
|
Synonyms | |
|
TargetDose | Highly dependent on patient status, usually 2-3 INR, once a day |
|
TitrationPeriod | |
|
TreatmentStatus | |
|
Treats | |
|
UMLSSynonyms | |
|
UsedTogetherWithMedication | |
|
UsedWithMedicationGroup | |
|
UseWhenExistsIntoleranceOf | |
|
UseWithTest |